TGF-β/Smad Signaling


The TGF-β family is generally classified into two sub-families, TGF-β ligands, and bone morphogenic protein (BMP) ligands. In canonical signaling, receptor activation lead to phosphorylation of a group of transcription factors called Smads. TGF-β ligands bind to type II receptors (TGF-β II) which recruit and phosphorylate type I receptor (TGF-β I) on serine/threonine residues. The TGF-β I then recruits and phosphorylates a receptor regulated Smad (R-Smad). The R-Smad binds to the common Smad (Co-Smad) and forms a heterodimeric complex. This complex then translocates into the cell nucleus where it binds with nuclear co-factors to regulate the transcription of various target genes. Dysregulation of TGF-β/Smad signaling pathway is associated with a number of pathological conditions including fibrosis, cancer, immunodeficiency, diabetes and cardiovascular diseases etc.
-
A3008 Y-27632 dihydrochloride81 CitationTarget: ROCKSummary: ROCK inhibitor -
B9001 Dibutyryl-cAMP, sodium salt11 CitationSummary: cell-permeable cAMP analog -
A8249 SB 43154231 CitationSummary: ALK5 inhibitor -
A8192 Staurosporine23 CitationSummary: serine/threonine protein kinases inhibitor -
B1293 Y-2763246 CitationTarget: ROCKSummary: ROCK inhibitor -
B6803 Rottlerin4 CitationTarget: PKC|Ca2 /calmodulin-dependent protein kinases (CaMKs)|PRAK|MAPKAP-K2Summary: PKC inhibitor -
A8232 Nilotinib(AMN-107)9 CitationTarget: Bcr-AblSummary: BCR-ABL inhibitor -
B7931 ButaprostSummary: Structural analog of PGE2, a selective agonist for the EP2 receptor subtype -
C4877 1,2-Distearoyl-sn-glycerolSummary: An internal standard for the separation and identification of DAG molecular species -
C4882 1,2-Dilauroyl-sn-glycerolSummary: A saturated diacylglycerol for the investigation of cell signal transduction mechanisms

